REQUEST A DEMO
Total
USD $0.00
Search more companies

GlaxoSmithKline Kft. (Hungary)

Main Activities: Pharmaceutical and Medicine Manufacturing
Secondary Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Pharmacies and Drug Stores
Full name: GlaxoSmithKline Gyogyszer- es Egeszsegvedelmi Termekek Kft. Profile Updated: July 24, 2019
Buy our report for this company USD 29.95 Most recent financial data: 2018 Available in: English & Hungarian Download a sample report

GlaxoSmithKline is a hungarian pharmaceutical company headquartered in the city of Budapest. The company has been incorporated in 2000 by the merger of Glaxo Wellcome and SmithKline Beecham. GlaxoSmithKline is one of the world’s leading research-oriented pharmaceutical and health prevention company, a leader in the manufacture of vaccines and healing infections and central nervous system and respiratory diseases. On the basis of total revenue, the company is one of the two hundred largest companies in Hungary.

Headquarters
Csorsz utca 43.
Budapest; Budapest; Postal Code: 1124

Contact Details: Purchase the GlaxoSmithKline Kft. report to view the information.

Website: http://www.gsk.hu

Basic Information
Total Employees:
Purchase the GlaxoSmithKline Kft. report to view the information.
Registered Capital:
Purchase the GlaxoSmithKline Kft. report to view the information.
Financial Auditors:
Purchase the GlaxoSmithKline Kft. report to view the information.
Incorporation Date:
June 23, 1993
Key Executives
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Subsidiaries
GSK Consumer Healthcare B.V. (Netherlands)
100%
GlaxoSmithKline Biologicals Kft.
100%
Company Performance
Financial values in the chart are available after GlaxoSmithKline Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
6.26%
Total operating revenue
1.97%
Operating profit (EBIT)
-14.77%
EBITDA
-14.58%
Net Profit (Loss) for the Period
-13.59%
Total assets
20.73%
Total equity
4.14%
Operating Profit Margin (ROS)
-0.76%
Net Profit Margin
-0.64%
Return on Equity (ROE)
-0.82%
Debt to Equity Ratio
-0.19%
Quick Ratio
-2.49%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?